Skip to content

Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients

Decrease Artery Occlusion by Distal Radial Arterial Cannulation in ACS Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05255939
Acronym
DONATION
Enrollment
1500
Registered
2022-02-25
Start date
2022-03-01
Completion date
2024-02-01
Last updated
2022-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Procedural Complication

Keywords

Distal Radial Access, Radial Artery Occlusion, Major Adverse Cardiovascular Events

Brief summary

The site of arterial access for coronary angiography and intervention has been the focus of research for decades as it is the source of major complications. Transradial access (TRA) reduces complications among patients undergoing percutaneous coronary procedures but is reported with the complication of radial artery occlusion (RAO) that limits the radial artery for future needs. Distal radial access (dTRA) has recently gained global popularity as an alternative access route for vascular procedures. Among the benefits of dTRA are the low risk of entry site bleeding complications, the low rate of radial artery occlusion, and improved patient and operator comfort. This study aims to reveal the feasibility and safety of dTRA and routine TRA procedures in acute coronary syndrome patients. The primary endpoints are forearm radical occlusion rate and major adverse cardiovascular events (MACEs) in the two groups, respectively. Investigators will also focus on puncture success in diagnostic and interventional cases, rate of One attempt success, access time, procedure time, crossover rate, contrast dose of patients, fluoroscopy time and dose, and healthcare cost of each group.

Interventions

PROCEDUREdistal TRA group

dTRA for PCI procedure to ACS patients.

PROCEDUREconventional TRA group

Conventional TRA for PCI procedure to ACS patients

Sponsors

Shenzhen People's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* presence of a pulse in the snuffbox

Exclusion criteria

* Absence of pulse * Ultrasound indication of arterial occlusion or severe calcification * Severe forearm artery malformation * Patients with severe liver and renal failure, or abnormal coagulation function * Established cardiogenic shock * History of previous coronary artery bypass grafting and radial artery use. * Raynaud's disease in the medical history

Design outcomes

Primary

MeasureTime frameDescription
Forearm radical occlusionduring procedureDoppler ultrasound to determine whether patients suffer forearm radial occlusion
MACEsduring procedureMajor Adverse Cardiovascular Events, including cardiovascular death, myocardial infarction and heart failure.

Secondary

MeasureTime frameDescription
Procedure timeduring procedureProcedure time of 2 kinds of procedure
Crossover rateduring procedureCrossover rate of 2 kinds of procedure
Contrast doseduring procedureContrast dose of 2 kinds of procedure
Rate of One attempt successduring procedureRate of One attempt success of 2 kinds of procedure
hand hematomaduring procedurehand hematoma rate of 2 kinds of procedure
The total cost in hospitalizationup to 2 yearsHealthcare cost .
Fluoroscopy doseduring procedureFluoroscopy dose of 2 kinds of procedure
Access timeduring procedureAccess time of 2 kinds of procedure

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026